Burroughs Wellcome clinical trials
Acquired by GlaxoSmithKline, Dec 27, 2000 · source ↗
The registry lists 1 studies whose lead sponsor is Burroughs Wellcome. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Jun 24, 2005.
- 1study on the registry
- 0open to participants now
Before and after it joined GlaxoSmithKline
- First submitted before Burroughs Wellcome became part of GlaxoSmithKline
- 1
- First submitted after Burroughs Wellcome became part of GlaxoSmithKline
- 0
- Unclear, or no submission date
- 0
By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.
What it is testing
The drugs Burroughs Wellcome’s studies test, most studies first; none is open now — 1 drug with a page of their own. Each count opens the studies in search.
Studies, none open
- 0 open · 1
All 1 at a glance
Where each study is in its life, its phase and its countries. Each count opens them in search.
- Completed1100%
Registry sponsor names on this page
- Burroughs Wellcome1 study
Something wrong with this grouping? Tell us on the GlaxoSmithKline page.
Studies
Recruiting first, then most recently updated. Showing 1 of 1. All GlaxoSmithKline studies →
- A Phase I Trial to Evaluate the Safety and Pharmacokinetics of 1592U89CompletedNCT00002141Phase 1
Sponsor listed in the registry: Burroughs Wellcome · First submitted before Burroughs Wellcome became part of GlaxoSmithKline